Google
×
Interpretation: In patients with atrial fibrillation, apixaban is similarly effective whether or not patients have had a previous stroke or TIA. Given that ...
People also ask
Feb 1, 2012 · we have shown that in patients with atrial fibrillation who are unsuitable for vitamin K antagonist therapy, apixaban reduced the risk of stroke ...
In patients with atrial fibrillation, apixaban is similarly effective whether or not patients have had a previous stroke or TIA.
In patients with atrial fibrillation, apixaban is similarly effective whether or not patients have had a previous stroke or TIA. Given that those with previous ...
Feb 10, 2011 · In the current study, apixaban as compared with aspirin reduced the risk of ischemic stroke by more than 60% but did not appear to increase the ...
May 25, 2022 · Among those with prior stroke/TIA/TE, patients treated with apixaban had less bleeding, death, or hospitalization than patients treated with ...
Aug 27, 2015 · Apixaban was associated with fewer strokes and systemic embolism versus aspirin across all subgroups; however, it caused more major bleeding events.
May 25, 2022 · Among those with prior stroke/TIA/TE, patients treated with apixaban had less bleeding, death, or hospitalization than patients treated with ...
Oct 2, 2012 · Apixaban reduces stroke with comparable bleeding risks when compared with aspirin in patients with atrial fibrillation who are unsuitable for vitamin k ...
Aug 30, 2011 · In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower ...